You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemo-naive HNSCC

Showing 1 - 25 of 2,504
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • IP chemotherapy
  • IP chemotherapy plus simvastatin
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center , Korea
Apr 4, 2022

HNSCC Trial in Saint-Mandé (Cisplatin, radiotherapy)

Recruiting
  • HNSCC
  • Saint-Mandé, France
    Hôpital Bégin
Mar 10, 2022

Extensive Stage Small Cell Lung Cancer Trial in Chicago, Indianapolis, Iowa City (Cisplatin, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Chicago, Illinois
  • +2 more
Jul 1, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Camrelizumab+cetuximab+chemo)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Shanghai, China
    Fudan University
Jan 4, 2023

Therapy Using 18F-FSPG PET

Not yet recruiting
  • Cancer
  • +3 more
  • 18F-FSPG PET/CT in NSCLC
  • 18F-FSPG PET/CT in HNSCC
  • (no location specified)
May 24, 2023

Xerostomia Trial in Stanford (drug, radiation, other)

Recruiting
  • Xerostomia
  • D-Limonene Gelcaps
  • +3 more
  • Stanford, California
    Stanford University
Mar 11, 2022

CTCs in HNSCC Patients Underwent Curative CCRT

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Circulating Tumor Cell
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital
    Aug 17, 2021

    Squamous Cell Head and Neck Carcinoma Trial (Durvalumab, radiotherapy, Placebo)

    Withdrawn
    • Squamous Cell Head and Neck Carcinoma
    • (no location specified)
    May 6, 2021

    Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • New York, New York
    • +1 more
    Nov 7, 2022

    HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)

    Recruiting
    • HNSCC
    • +4 more
    • blood draws
    • Groningen, Netherlands
      University Medical Center Groningen (UMCG)
    Aug 23, 2023

    Head and Neck Squamous Cell Carcinoma Trial (MRI)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • MRI
    • (no location specified)
    Jun 21, 2023

    Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)

    Completed
    • Prostate Cancer Metastatic
    • Leiden, Netherlands
      Leiden University Medical Center
    Apr 6, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Pembrolizumab (Keytruda®), SAR444245 (Thor-707), Cetuximab

    Active, not recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Pembrolizumab (Keytruda®)
    • +2 more
    • Duarte, California
    • +39 more
    Oct 31, 2022

    Head Neck Cancer Trial in Germany (procedure, radiation, drug)

    Active, not recruiting
    • Head and Neck Cancer
    • Surgical resection of primary tumor
    • +4 more
    • Ulm, Baden-Württemberg, Germany
    • +6 more
    Dec 9, 2020

    Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (Nimotuzumab, Placebo)

    Active, not recruiting
    • Carcinoma, Squamous Cell of Head and Neck
    • Bedford Park, Australia
    • +29 more
    Apr 4, 2022

    Microbiome in Head and Neck Squamous Cell Carcinoma

    Not yet recruiting
    • Head and Neck Cancer
    • +3 more
    • Metagenomic sequencing
    • Metabolic analysis
    • Aurora, Colorado
      University of Colorado Cancer Center
    Apr 19, 2023

    Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

    Not yet recruiting
    • Sinonasal Cancer
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 5, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Belgium (Dose de-escalation and / or Volume de-escalation)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Dose de-escalation and / or Volume de-escalation
    • Brussel, Belgium
    • +3 more
    Jan 25, 2022

    Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
      • Kingston Upon Thames, United Kingdom
      • +1 more
      Dec 7, 2022

      Squamous Cell Carcinoma of the Head and Neck Trial in Le Havre (Pembrolizumab, Cetuximab, Radiotherapy)

      Active, not recruiting
      • Squamous Cell Carcinoma of the Head and Neck
      • Le Havre, France
        Centre Guillaume le conquérant
      Aug 18, 2022

      Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)

      Withdrawn
      • Prostatic Neoplasms, Castration-Resistant
      • (no location specified)
      Nov 15, 2020

      Prostatic Tumors, Castration-Resistant Trial in China, Korea, Republic of, Taiwan (Tasquinimod, Placebo)

      Terminated
      Has Results
      • Prostatic Neoplasms, Castration-Resistant
      • Beijing, Beijing, China
      • +35 more
      Mar 24, 2021

      NSCLC Trial in United States (Erlotinib, Hydroxychloroquine)

      Unknown status
      Has Results
      • Non-small Cell Lung Cancer
      • Stanford, California
      • +3 more
      Jul 1, 2020

      Head and Neck Squamous Cell Carcinoma Trial in Brescia (Niraparib)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Brescia, Italy
        Asst Degli Spedali Civili Di Brescia
      Aug 3, 2022

      Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) Trial in United States (pepinemab + pembrolizumab)

      Recruiting
      • Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
      • pepinemab + pembrolizumab
      • Springdale, Arkansas
      • +17 more
      Dec 7, 2022